Zucara Therapeutics
Latest round
- Series B
Last raised
- May 2025
Total raised
- $46M
Investors
- 3
About Zucara Therapeutics
, based in Canada, develops innovative treatments for diabetes, focusing on preventing hypoglycemia in patients with Type 1 diabetes through its proprietary therapeutic solution ZT-01. Founded in 2015 and headquartered in Vancouver, Canada, Zucara Therapeutics Inc. is dedicated to creating therapies that address unmet medical needs in diabetes management. Richard Liggins serves as the founder, and Michael Midmer is the CEO. Zucara has successfully completed a total of 9 deals, In May 2025, Zucara Therapeutics Inc. Zucara Therapeutics is focused on developing a groundbreaking therapeutic solution, ZT-01, aimed at preventing hypoglycemia in individuals with diabetes, particularly Type 1 diabetes. This once-daily treatment works by targeting and blocking somatostatin type 2 receptors in the pancreas, thereby restoring the body’s ability to produce glucagon and counteract low blood sugar levels. The end users of this product include insulin-treated patients, who often face the risks associated with hypoglycemia, impacting their health, quality of life, and diabetes management. The company’s innovation offers a preventative measure as opposed to existing therapies, which primarily provide rescue solutions during hypoglycemic episodes. While specific revenue figures are not disclosed, Zucara’s financial model will likely involve partnerships with healthcare providers and potential collaborations with pharmaceutical companies.In May 2025, Zucara Therapeutics Inc.
Who invested in Zucara Therapeutics
3 investors across 3 rounds
See all investors in Zucara Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Zucara Therapeutics
Who invested in Zucara Therapeutics?
Zucara Therapeutics has 3 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Zucara Therapeutics raised?
Zucara Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Zucara Therapeutics last raise money?
Zucara Therapeutics's most recent round on record is a Series B, in May 2025.
What does Zucara Therapeutics do?
, based in Canada, develops innovative treatments for diabetes, focusing on preventing hypoglycemia in patients with Type 1 diabetes through its proprietary therapeutic solution ZT-01.
Where is Zucara Therapeutics headquartered?
Zucara Therapeutics is headquartered in Vancouver, Canada.
Which VCs invest in companies like Zucara Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Zucara Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Zucara Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.